Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    August 2017
  1. BEST MG, Sol N, In 't Veld SGJG, Vancura A, et al
    Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Cancer Cell. 2017;32:238-252.
    PubMed     Text format     Abstract available


    April 2017
  2. SCHOENFELD JD, Sibenaller ZA, Mapuskar KA, Wagner BA, et al
    O2- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
    Cancer Cell. 2017;31:487-500.
    PubMed     Text format     Abstract available


    March 2017
  3. WIELAND E, Rodriguez-Vita J, Liebler SS, Mogler C, et al
    Endothelial Notch1 Activity Facilitates Metastasis.
    Cancer Cell. 2017;31:355-367.
    PubMed     Text format     Abstract available


    February 2017
  4. GARDNER EE, Lok BH, Schneeberger VE, Desmeules P, et al
    Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
    Cancer Cell. 2017;31:286-299.
    PubMed     Text format     Abstract available


  5. JUSTILIEN V, Ali SA, Jamieson L, Yin N, et al
    Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
    Cancer Cell. 2017;31:256-269.
    PubMed     Text format     Abstract available


  6. BERNS K, Berns A
    Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.
    Cancer Cell. 2017;31:169-171.
    PubMed     Text format     Abstract available


    December 2016
  7. MOLLAOGLU G, Guthrie MR, Bohm S, Bragelmann J, et al
    MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
    Cancer Cell. 2016 Dec 31. pii: S1535-6108(16)30600.
    PubMed     Text format     Abstract available


    July 2016
  8. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2016 Jul 28. pii: S1535-6108(16)30282.
    PubMed     Text format     Abstract available


  9. SAHA S, Biswas SK
    Tumor-Associated Neutrophils Show Phenotypic and Functional Divergence in Human Lung Cancer.
    Cancer Cell. 2016;30:11-3.
    PubMed     Text format     Abstract available


    June 2016
  10. SINGHAL S, Bhojnagarwala PS, O'Brien S, Moon EK, et al
    Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.
    Cancer Cell. 2016 Jun 30. pii: S1535-6108(16)30226.
    PubMed     Text format     Abstract available


    May 2016
  11. BRADY JJ, Chuang CH, Greenside PG, Rogers ZN, et al
    An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
    Cancer Cell. 2016;29:697-710.
    PubMed     Text format     Abstract available


    April 2016
  12. FORTIN J, Mak TW
    Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs.
    Cancer Cell. 2016;29:429-31.
    PubMed     Text format     Abstract available


  13. FREED DM, Park JH, Radhakrishnan R, Lemmon MA, et al
    Deletion Mutations Keep Kinase Inhibitors in the Loop.
    Cancer Cell. 2016;29:423-5.
    PubMed     Text format     Abstract available


  14. HALAMA N, Zoernig I, Berthel A, Kahlert C, et al
    Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Cancer Cell. 2016;29:587-601.
    PubMed     Text format     Abstract available


  15. WANG Q, Yu WN, Chen X, Peng XD, et al
    Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.
    Cancer Cell. 2016;29:523-35.
    PubMed     Text format     Abstract available


    March 2016
  16. ALI SA, Justilien V, Jamieson L, Murray NR, et al
    Protein Kinase Ciota Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.
    Cancer Cell. 2016;29:367-78.
    PubMed     Text format     Abstract available


    January 2016
  17. SERRESI M, Gargiulo G, Proost N, Siteur B, et al
    Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.
    Cancer Cell. 2016;29:17-31.
    PubMed     Text format     Abstract available


    September 2015
  18. WANG X, Zhao X, Feng C, Weinstein A, et al
    IL-36gamma Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.
    Cancer Cell. 2015;28:296-306.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: